RRD Simplifies the Production and Distribution of Medical Device Recall Notices
R.R. Donnelley & Sons Company (RRD), a leading global provider of marketing, packaging, print, and supply chain solutions, today announced a new solution designed to streamline the product recall communication process for medical device companies. Seamlessly integrating RRD’s highly refined…
Exo Works™ Achieves HITRUST and SOC 2 Type II Certifications, Meeting Highest Bar for Patient Data Security
A pioneering medical imaging software and devices company, today announced that Exo Works™, the company’s point-of-care ultrasound workflow solution, has earned Certified status for information security by HITRUST and has successfully completed the Service Organization Control (SOC 2) Type II certification. These achievements provide additional…
EnChroma and UNC’s Department of Health Sciences Team to Help Color Blind Students Address Challenges to Learning on Campus
EnChroma – creators of glasses for color blindness – and the University of North Carolina at Chapel Hill’s Department of Health Sciencestoday announced that special EnChroma glasses for color blindness will be available for students, faculty and staff who are Color Vision Deficient…
Veristat félicite HIPRA pour l’approbation par l’EMA de son vaccin BIMERVAX®contre COVID-19
Veristat, une organisation mondiale de recherche clinique (CRO) à l’esprit scientifique, a félicité aujourd’hui HIPRA pour l’autorisation de mise sur le marché par l’Agence européenne des médicaments (EMA) et la Commission européenne de BIMERVAX®, un vaccin bivalent avec adjuvant basé sur les…
Orthofix Expands Solutions for Minimally Invasive Spine Procedures with the Full Commercial Launch of Two Access Retractor Systems
a leading global spine and orthopedics company, today announced the full commercial launch of two access retractor systems to aid surgeons during minimally invasive spine (MIS) procedures. The Lattus™ Lateral Access System and the Fathom™ Pedicle-Based Retractor System expand the Company’s offering of access…
Elucid Names Scott Huennekens Executive Chairman of the Board
A leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, today announced that it has named Scott Huennekens executive chairman of its board of directors. “Having Scott join us as executive chairman at this…
Myrtelle’s rAAV-Olig001-ASPA Gene Therapy Candidate for Canavan Disease Receives Innovative Licensing and Access Pathway Designation from the UK Medicines and Healthcare Products Regulatory Agency
“Myrtelle” or the “Company”, a clinical stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases, today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA), the healthcare regulatory body of the United Kingdom (UK), granted Innovative…
Juno Pharmaceuticals Partners With Rosemont Pharmaceuticals as Exclusive Canadian Distributor to Offer Previously Inaccessible Medicines
Juno Pharmaceuticals Canada (“Juno”), a Canadian specialty pharmaceutical company, announced its partnership with U.K. based developer, manufacturer and global supplier of novel, Rx, oral liquid medicines, Rosemont Pharmaceuticals (“Rosemont”), as its exclusive Canadian distributor. Through this partnership, several of Rosemont’s…
Juno Pharmaceuticals entre en partenariat avec Rosemont Pharmaceuticals en tant que distributeur canadien exclusif pour offrir des médicaments auparavant inaccessibles
Juno Pharmaceuticals Canada (« Juno »), une société pharmaceutique canadienne spécialisée, annonce son partenariat avec Rosemont Pharmaceuticals (« Rosemont ») pour devenir son distributeur canadien exclusif. Rosemont est une entreprise établie au Royaume-Uni qui développe, fabrique et fournit des médicaments…
Enanta Pharmaceuticals Announces Sale of a Portion of Global Royalties on MAVYRET® (U.S.)/MAVIRET® (ex-U.S.) (Glecaprevir/Pibrentasvir) to OMERS Life Sciences for $200 Million
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced the sale to OMERS, one of Canada’s largest defined benefit pension plans, of 54.5% of Enanta’s future royalty payments from…
VBI Vaccines Appoints Vaughn Himes to Board of Directors
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Vaughn B. Himes, Ph.D., Chief Technical Officer of Seagen Inc., has joined VBI’s Board of…
MiNA Therapeutics Enters Research Collaboration with BioMarin Pharmaceutical to Advance RNAa Platform Research in Rare Genetic Diseases
MiNA Therapeutics, the pioneer of small activating RNA (RNAa) therapeutics, today announced a multi-target research collaboration and option licensing agreement with BioMarin Pharmaceutical Inc. The collaboration will allow for the discovery, and potential development and commercialization of RNAa therapeutic candidates…